Mitchell et al.. The Exosome: A Conserved Eukaryotic RNA Processing Complex Containing Multiple 3′→5′ Exoribonucleases. 91, 1997, p. 457–466. DOI10.1016/S0092-8674(00)80432-8.
Allmang et al.. The yeast exosome and human PM-Scl are related complexes of 3'→ 5' exonucleases. 13, 1999, p. 2148–58. DOI10.1101/gad.13.16.2148.
Brouwer et al.. Three novel components of the human exosome. 276, 2001, p. 6177–84. DOI10.1074/jbc.M007603200.
Chen et al.. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. 107, 2001, p. 451–64. DOI10.1016/S0092-8674(01)00578-5.
Koonin et al.. Prediction of the archaeal exosome and its connections with the proteasome and the translation and transcription machineries by a comparative-genomic approach. 11, 2001, p. 240–52. DOI10.1101/gr.162001.
Evguenieva-Hackenberg et al.. An exosome-like complex in Sulfolobus solfataricus. 4, 2003, p. 889–93. DOI10.1038/sj.embor.embor929.
Schilders et al.. Cell and molecular biology of the exosome: how to make or break an RNA. 251, 2006, p. 159–208. DOI10.1016/S0074-7696(06)51005-8.
Lorentzen et al.. The archaeal exosome core is a hexameric ring structure with three catalytic subunits. 12, 2005, p. 575–81. DOI10.1038/nsmb952.
Raijmakers et al.. Protein-protein interactions between human exosome components support the assembly of RNase PH-type subunits into a six-membered PNPase-like ring. 323, 2002, p. 653–63. DOI10.1016/S0022-2836(02)00947-6.
Walter et al.. Characterization of native and reconstituted exosome complexes from the hyperthermophilic archaeon Sulfolobus solfataricus. 62, 2006, p. 1076–89. DOI10.1111/j.1365-2958.2006.05393.x.
Ishii et al.. Crystal structure of the tRNA processing enzyme RNase PH from Aquifex aeolicus. 278, 2003, p. 32397–404. DOI10.1074/jbc.M300639200.
Symmons et al.. A duplicated fold is the structural basis for polynucleotide phosphorylase catalytic activity, processivity, and regulation. 8, 2000, p. 1215–26. DOI10.1016/S0969-2126(00)00521-9.
Lin-Chao et al.. The PNPase, exosome and RNA helicases as the building components of evolutionarily-conserved RNA degradation machines. 14, 2007, p. 523–32. DOI10.1007/s11373-007-9178-y.
Harlow et al.. Crystal structure of the phosphorolytic exoribonuclease RNase PH from Bacillus subtilis and implications for its quaternary structure and tRNA binding. 13, 2004, p. 668–77. DOI10.1110/ps.03477004.
Schneider et al.. The exosome subunit Rrp44 plays a direct role in RNA substrate recognition. 27, 2007, p. 324–31. DOI10.1016/j.molcel.2007.06.006.
Mian et al.. Comparative sequence analysis of ribonucleases HII, III, II PH and D. 25, 1997, p. 3187–3195. DOI10.1093/nar/25.16.3187.
Raijmakers et al.. The exosome, a molecular machine for controlled RNA degradation in both nucleus and cytoplasm. 83, 2004, p. 175–83. DOI10.1078/0171-9335-00385.
Wang et al.. Domain interactions within the Ski2/3/8 complex and between the Ski complex and Ski7p. 11, 2005, p. 1291–302. DOI10.1261/rna.2060405.
LaCava et al.. RNA degradation by the exosome is promoted by a nuclear polyadenylation complex. 121, 2005, p. 713–24. DOI10.1016/j.cell.2005.04.029.
Liu et al.. Erratum: Reconstitution, activities, and structure of the eukaryotic RNA exosome. 131, 2007, p. 188–189. DOI10.1016/j.cell.2007.09.019.
Dziembowski et al.. A single subunit, Dis3, is essentially responsible for yeast exosome core activity. 14, 2007, p. 15–22. DOI10.1038/nsmb1184.
Liu et al.. Reconstitution, activities, and structure of the eukaryotic RNA exosome. 127, 2006, p. 1223–37. DOI10.1016/j.cell.2006.10.037.
Lorentzen et al.. Structural basis of 3' end RNA recognition and exoribonucleolytic cleavage by an exosome RNase PH core. 20, 2005, p. 473–81. DOI10.1016/j.molcel.2005.10.020.
LeJeune et al.. Nonsense-mediated mRNA decay in mammalian cells involves decapping, deadenylating, and exonucleolytic activities. 12, 2003, p. 675–87. DOI10.1016/S1097-2765(03)00349-6.
Wilson et al.. A genomic screen in yeast reveals novel aspects of nonstop mRNA metabolism. 177, 2007, p. 773. DOI10.1534/genetics.107.073205.
Lin et al.. Localization of AU-rich element-containing mRNA in cytoplasmic granules containing exosome subunits. 282, 2007, p. 19958–68. DOI10.1074/jbc.M702281200.
Allmang et al.. Functions of the exosome in rRNA, snoRNA and snRNA synthesis. 18, 1999, p. 5399–410. DOI10.1093/emboj/18.19.5399.
Schilders et al.. MPP6 is an exosome-associated RNA-binding protein involved in 5.8S rRNA maturation. 33, 2005, p. 6795–804. DOI10.1093/nar/gki982.
van Dijk et al.. Human cell growth requires a functional cytoplasmic exosome, which is involved in various mRNA decay pathways. 13, 2007, p. 1027–35. DOI10.1261/rna.575107.
Houseley J, LaCava J, Tollervey D «RNA-quality control by the exosome». Nat. Rev. Mol. Cell Biol., 7, 7, Juliol 2006, pàg. 529–39. DOI: 10.1038/nrm1964. PMID: 16829983.
Wyers F, Rougemaille M, Badis G, et al «Cryptic pol II transcripts are degraded by a nuclear quality control pathway involving a new poly(A) polymerase». Cell, 121, 5, Juny 2005, pàg. 725–37. DOI: 10.1016/j.cell.2005.04.030. PMID: 15935759.
Neil H, Malabat C, d'Aubenton-Carafa Y, Xu Z, Steinmetz LM, Jacquier A «Widespread bidirectional promoters are the major source of cryptic transcripts in yeast». Nature, 457, 7232, Febrer 2009, pàg. 1038–42. DOI: 10.1038/nature07747. PMID: 19169244.
Preker P, Nielsen J, Kammler S, et al «RNA exosome depletion reveals transcription upstream of active human promoters». Science, 322, 5909, Desembre 2008, pàg. 1851–4. DOI: 10.1126/science.1164096. PMID: 19056938.
Targoff et al.. Nucleolar localization of the PM-Scl antigen. 28, 1985, p. 226–30. DOI10.1002/art.1780280221.
Raijmakers et al.. PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome. 50, 2004, p. 565–9. DOI10.1002/art.20056.
Brouwer et al.. {{{títol}}}. 4, 2002, p. 134–8. DOI10.1186/ar389.
Schilders et al.. C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome. 56, 2007, p. 2449–54. DOI10.1002/art.22710.
Mahler et al.. Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen. 7, 2005, p. R704–13. DOI10.1186/ar1729.
Mahler et al.. Novel aspects of autoantibodies to the PM/Scl complex: Clinical, genetic and diagnostic insights. 6, 2007, p. 432–7. DOI10.1016/j.autrev.2007.01.013.
Jablonska et al.. Scleromyositis: a scleroderma/polymyositis overlap syndrome. 17, 1998, p. 465–7. DOI10.1007/BF01451281.
Lum et al.. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. 116, 2004, p. 121–37. DOI10.1016/S0092-8674(03)01035-3.
nih.gov
ncbi.nlm.nih.gov
Lebreton et al. «Endonucleolytic RNA cleavage by a eukaryotic exosome.». Nature, 456, 2008, pàg. 993-6. PMID: 19060886.
Schneider et al. «The N-terminal PIN domain of the exosome subunit Rrp44 harbors endonuclease activity and tethers Rrp44 to the yeast core exosome.». Nucleic Acids Research, 37, 2009, pàg. 1127-40. PMID: 19129231.
Houseley J, LaCava J, Tollervey D «RNA-quality control by the exosome». Nat. Rev. Mol. Cell Biol., 7, 7, Juliol 2006, pàg. 529–39. DOI: 10.1038/nrm1964. PMID: 16829983.
Wyers F, Rougemaille M, Badis G, et al «Cryptic pol II transcripts are degraded by a nuclear quality control pathway involving a new poly(A) polymerase». Cell, 121, 5, Juny 2005, pàg. 725–37. DOI: 10.1016/j.cell.2005.04.030. PMID: 15935759.
Neil H, Malabat C, d'Aubenton-Carafa Y, Xu Z, Steinmetz LM, Jacquier A «Widespread bidirectional promoters are the major source of cryptic transcripts in yeast». Nature, 457, 7232, Febrer 2009, pàg. 1038–42. DOI: 10.1038/nature07747. PMID: 19169244.
Preker P, Nielsen J, Kammler S, et al «RNA exosome depletion reveals transcription upstream of active human promoters». Science, 322, 5909, Desembre 2008, pàg. 1851–4. DOI: 10.1126/science.1164096. PMID: 19056938.